Effects of cannabidiol in males and females in two different rat models of depression

Abstract:

The current study explores the therapeutic potential of Cannabidiol (CBD), a compound in the Cannabis plant, using both sexes of 2 “depressive-like” genetic models, Wistar Kyoto (WKY) and Flinders Sensitive Line (FSL) rats. Rats ingested CBD (30 mg/kg) orally. In the saccharin preference test, following a previous report of a pro-hedonic effect of CBD in male WKY, we now found similar results in female WKY. CBD also decreased immobility in the forced swim test in males (both strains) and in female WKY. These findings suggest a role for CBD in treating mental disorders with prominent symptoms of helplessness and anhedonia.

Read the full study here: https://www.sciencedirect.com/science/article/abs/pii/S0031938418307509

Liat Shbiro, Danielle Hen-Shoval, Noa Hazut, Kayla Rapps, Shira Dar, Gil Zalsman, Raphael Mechoulam, Aron Weller, Gal Shoval,
Effects of cannabidiol in males and females in two different rat models of depression,
Physiology & Behavior,
Volume 201,
2019,
Pages 59-63,
ISSN 0031-9384,
https://doi.org/10.1016/j.physbeh.2018.12.019.